243 related articles for article (PubMed ID: 10569734)
1. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.
Ascón MA; Hone DM; Walters N; Pascual DW
Infect Immun; 1998 Nov; 66(11):5470-6. PubMed ID: 9784559
[TBL] [Abstract][Full Text] [Related]
3. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
[TBL] [Abstract][Full Text] [Related]
4. Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector.
Pascual DW; White MD; Larson T; Walters N
J Immunol; 2001 Jul; 167(1):407-15. PubMed ID: 11418677
[TBL] [Abstract][Full Text] [Related]
5. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
6. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H; Schifferli DM
Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
[TBL] [Abstract][Full Text] [Related]
7. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.
VanCott JL; Staats HF; Pascual DW; Roberts M; Chatfield SN; Yamamoto M; Coste M; Carter PB; Kiyono H; McGhee JR
J Immunol; 1996 Feb; 156(4):1504-14. PubMed ID: 8568254
[TBL] [Abstract][Full Text] [Related]
9. New vaccine strategies against enterotoxigenic Escherichia coli. II: Enhanced systemic and secreted antibody responses against the CFA/I fimbriae by priming with DNA and boosting with a live recombinant Salmonella vaccine.
Lásaro MO; Alves AM; Guillobel HC; Almeida DF; Ferreira LC
Braz J Med Biol Res; 1999 Feb; 32(2):241-6. PubMed ID: 10347761
[TBL] [Abstract][Full Text] [Related]
10. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
Byrd W; Boedeker EC
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
[TBL] [Abstract][Full Text] [Related]
11. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies protect against intraperitoneal challenge with enterotoxigenic Escherichia coli.
Yang X; Thornburg T; Holderness K; Suo Z; Cao L; Lim T; Avci R; Pascual DW
J Biomed Biotechnol; 2011; 2011():632396. PubMed ID: 22007145
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin.
Byrd W; Cassels FJ
Vaccine; 2003 May; 21(17-18):1884-93. PubMed ID: 12706673
[TBL] [Abstract][Full Text] [Related]
14. Immunization against the colonization factor antigen I of enterotoxigenic Escherichia coli by administration of a bivalent Salmonella typhimurium aroA strain.
Guillobel HC; Luna MG; Camacho EF; Almeida DF; Ferreira LC
Braz J Med Biol Res; 1998 Apr; 31(4):545-54. PubMed ID: 9698808
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR.
Wu S; Pascual DW; VanCott JL; McGhee JR; Maneval DR; Levine MM; Hone DM
Infect Immun; 1995 Dec; 63(12):4933-8. PubMed ID: 7591160
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain.
Guillobel HC; Carinhanha JI; Cárdenas L; Clements JD; de Almeida DF; Ferreira LC
Infect Immun; 2000 Jul; 68(7):4349-53. PubMed ID: 10858258
[TBL] [Abstract][Full Text] [Related]
17. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
Huang Y; Hajishengallis G; Michalek SM
Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
[TBL] [Abstract][Full Text] [Related]
18. The role of Th1 and Th2 cells for mucosal IgA responses.
Yamamoto M; Vancott JL; Okahashi N; Marinaro M; Kiyono H; Fujihashi K; Jackson RJ; Chatfield SN; Bluethmann H; McGhee JR
Ann N Y Acad Sci; 1996 Feb; 778():64-71. PubMed ID: 8611017
[TBL] [Abstract][Full Text] [Related]
19. A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine.
Jun S; Gilmore W; Callis G; Rynda A; Haddad A; Pascual DW
J Immunol; 2005 Nov; 175(10):6733-40. PubMed ID: 16272329
[TBL] [Abstract][Full Text] [Related]
20. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
